Massachusetts Financial Services’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$939K Sell
112,011
-2,977
-3% -$31.3K ﹤0.01% 850
2025
Q4
$1.66M Sell
114,988
-3,807
-3% -$47.5K ﹤0.01% 803
2025
Q3
$1.15M Buy
118,795
+98,295
+479% +$869K ﹤0.01% 797
2025
Q2
$168K Buy
+20,500
New +$172K ﹤0.01% 878
2023
Q3
Sell
-23,273
Closed -$465K 866
2023
Q2
$465K Sell
23,273
-26,184
-53% -$504K ﹤0.01% 792
2023
Q1
$935K Buy
49,457
+4,911
+11% +$109K ﹤0.01% 770
2022
Q4
$1.01M Buy
44,546
+943
+2% +$21.3K ﹤0.01% 775
2022
Q3
$1.15M Buy
+43,603
New +$1.29M ﹤0.01% 771

Other funds holding RGNX